Every drug starts with an idea. But it takes knowledge, experience, creativity, and vision to transform ideas into small molecules, then small molecules into clinical candidates. That’s why for more than 30 years the world’s leading pharma and biotech companies have made us part of their team.
From hit generation, lead optimisation and computational chemistry to API development and clinical supply, Symeres is ready to help create new therapies for unmet needs in the pharmaceutical and veterinary industries. With over 500 scientists, we offer best-in-class solutions for drug discovery and drug development for small molecules and beyond. We blend a deep scientific knowledge base with creativity to deliver the quality results your project needs.
We aim to have real positive impact on people’s lives around the world. We make molecules matter. Together.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner